239 related articles for article (PubMed ID: 30068648)
1. Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses.
Yuan L; Zhang S; Wang Y; Li Y; Wang X; Yang Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30068648
[TBL] [Abstract][Full Text] [Related]
2.
Wang X; Hu W; Zhu L; Yang Q
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28270576
[TBL] [Abstract][Full Text] [Related]
3. Synthetic surfactin analogues have improved anti-PEDV properties.
Yuan L; Zhang S; Peng J; Li Y; Yang Q
PLoS One; 2019; 14(4):e0215227. PubMed ID: 30973929
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis.
Vollenbroich D; Ozel M; Vater J; Kamp RM; Pauli G
Biologicals; 1997 Sep; 25(3):289-97. PubMed ID: 9324997
[TBL] [Abstract][Full Text] [Related]
5. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
6. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
7. Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity.
Johnson BA; Hage A; Kalveram B; Mears M; Plante JA; Rodriguez SE; Ding Z; Luo X; Bente D; Bradrick SS; Freiberg AN; Popov V; Rajsbaum R; Rossi S; Russell WK; Menachery VD
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462558
[TBL] [Abstract][Full Text] [Related]
8. In vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus.
Li L; Yu X; Zhang H; Cheng H; Hou L; Zheng Q; Hou J
Virus Genes; 2019 Apr; 55(2):174-181. PubMed ID: 30637608
[TBL] [Abstract][Full Text] [Related]
9. A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.
Vigant F; Lee J; Hollmann A; Tanner LB; Akyol Ataman Z; Yun T; Shui G; Aguilar HC; Zhang D; Meriwether D; Roman-Sosa G; Robinson LR; Juelich TL; Buczkowski H; Chou S; Castanho MA; Wolf MC; Smith JK; Banyard A; Kielian M; Reddy S; Wenk MR; Selke M; Santos NC; Freiberg AN; Jung ME; Lee B
PLoS Pathog; 2013; 9(4):e1003297. PubMed ID: 23637597
[TBL] [Abstract][Full Text] [Related]
10. DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding.
Li CM; Zheng LL; Yang XX; Wan XY; Wu WB; Zhen SJ; Li YF; Luo LF; Huang CZ
Biomaterials; 2016 Jan; 77():216-26. PubMed ID: 26606447
[TBL] [Abstract][Full Text] [Related]
11. 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses.
Colpitts CC; Ustinov AV; Epand RF; Epand RM; Korshun VA; Schang LM
J Virol; 2013 Apr; 87(7):3640-54. PubMed ID: 23283943
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Chong H; Zhu Y; Yu D; He Y
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089693
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication.
Su M; Shi D; Xing X; Qi S; Yang D; Zhang J; Han Y; Zhu Q; Sun H; Wang X; Wu H; Wang M; Wei S; Li C; Guo D; Feng L; Sun D
J Virol; 2021 Jul; 95(16):e0018721. PubMed ID: 34037422
[TBL] [Abstract][Full Text] [Related]
14. Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.
Zhu Y; Chong H; Yu D; Guo Y; Zhou Y; He Y
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867304
[TBL] [Abstract][Full Text] [Related]
15. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
Krepstakies M; Lucifora J; Nagel CH; Zeisel MB; Holstermann B; Hohenberg H; Kowalski I; Gutsmann T; Baumert TF; Brandenburg K; Hauber J; Protzer U
J Infect Dis; 2012 Jun; 205(11):1654-64. PubMed ID: 22457281
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of eGFP-Marked Recombinant Lactobacillus casei against Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus.
Yu M; Wang L; Ma S; Wang X; Wang Y; Xiao Y; Jiang Y; Qiao X; Tang L; Xu Y; Li Y
Viruses; 2017 Sep; 9(10):. PubMed ID: 28946696
[TBL] [Abstract][Full Text] [Related]
17. Antigenic relationships among porcine epidemic diarrhea virus and transmissible gastroenteritis virus strains.
Lin CM; Gao X; Oka T; Vlasova AN; Esseili MA; Wang Q; Saif LJ
J Virol; 2015 Mar; 89(6):3332-42. PubMed ID: 25589635
[TBL] [Abstract][Full Text] [Related]
18. Surface-Displayed Porcine IFN-λ3 in
Liu YS; Liu Q; Jiang YL; Yang WT; Huang HB; Shi CW; Yang GL; Wang CF
J Microbiol Biotechnol; 2020 Apr; 30(4):515-525. PubMed ID: 31838830
[TBL] [Abstract][Full Text] [Related]
19. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
[TBL] [Abstract][Full Text] [Related]
20. Decreased NHE3 activity in intestinal epithelial cells in TGEV and PEDV-induced piglet diarrhea.
Niu Z; Zhang Y; Kan Z; Ran L; Yan T; Xu S; Zhang S; Zhang J; Zou H; Song Z
Vet Microbiol; 2021 Dec; 263():109263. PubMed ID: 34749283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
